Literature DB >> 11964337

Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies.

Josie M M Evans1, Jixian Wang, Andrew D Morris.   

Abstract

OBJECTIVE: To compare risks of cardiovascular outcomes between patients with type 2 diabetes and patients with established coronary heart disease.
DESIGN: Cross sectional study and cohort study using routinely collected datasets.
SETTING: Tayside, Scotland (population 400 000) during 1988-95.
SUBJECTS: In the cross sectional study, among patients aged 45-64, 1155 with type 2 diabetes were compared with 1347 who had had a myocardial infarction in the preceding 8 years. In the cohort study 3477 patients of all ages with newly diagnosed type 2 diabetes were compared with 7414 patients who had just had a myocardial infarction. MAIN OUTCOME MEASURES: Risk ratios for death from all causes, cardiovascular death, and hospital admission for myocardial infarction were calculated by Cox proportional hazards analysis and adjusted for age and sex.
RESULTS: In the cross sectional study the adjusted risk ratio for death from all causes for patients who had myocardial infarction compared with those with diabetes was 1.33 (95% confidence interval 1.14 to 1.55) [corrected], and the risk ratio for hospital admission for myocardial infarction was 2.27 (1.82 to 2.83) [corrected]. In the cohort study, patients who had just had a myocardial infarction had a higher risk of death from all causes (adjusted risk ratio 1.35 (1.25 to 1.44)), cardiovascular death (2.93 (2.54 to 3.41)), and hospital admission for myocardial infarction (3.10 (2.57 to 3.73)).
CONCLUSIONS: Patients with type 2 diabetes were at lower risk of cardiovascular outcomes than patients with established coronary heart disease.

Entities:  

Mesh:

Year:  2002        PMID: 11964337      PMCID: PMC102325          DOI: 10.1136/bmj.324.7343.939

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  9 in total

1.  Diabetes care needs evidence based interventions to reduce risk of vascular disease.

Authors:  C D Byrne; S H Wild
Journal:  BMJ       Date:  2000-06-10

2.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

Authors:  I M Stratton; A I Adler; H A Neil; D R Matthews; S E Manley; C A Cull; D Hadden; R C Turner; R R Holman
Journal:  BMJ       Date:  2000-08-12

3.  The diabetes audit and research in Tayside Scotland (DARTS) study: electronic record linkage to create a diabetes register. DARTS/MEMO Collaboration.

Authors:  A D Morris; D I Boyle; R MacAlpine; A Emslie-Smith; R T Jung; R W Newton; T M MacDonald
Journal:  BMJ       Date:  1997-08-30

4.  Diabetes and coronary heart disease.

Authors:  L A Simons; J Simons
Journal:  N Engl J Med       Date:  1998-12-03       Impact factor: 91.245

5.  Cardiovascular disease and risk factors in persons with type 2 diabetes diagnosed in a large population screening: the Nord-Trøndelag Diabetes Study, Norway.

Authors:  T Claudi; K Midthjell; J Holmen; K Fougner; O Krüger; R Wiseth
Journal:  J Intern Med       Date:  2000-12       Impact factor: 8.989

6.  Country profile: Sweden.

Authors:  J Calltorp; H O Adami; H Aström; L Fryklund; S Rossner; Y Trolle; J Giesecke
Journal:  Lancet       Date:  1996-03-02       Impact factor: 79.321

7.  A study to determine the sensitivity and specificity of hospital discharge diagnosis data used in the MICA study.

Authors:  R McAlpine; S Pringle; T Pringle; R Lorimer; T M MacDonald
Journal:  Pharmacoepidemiol Drug Saf       Date:  1998-09       Impact factor: 2.890

8.  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Authors:  J Stamler; O Vaccaro; J D Neaton; D Wentworth
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

9.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

  9 in total
  63 in total

1.  Cardiovascular risk scores and prescribing in diabetes. Using risk tables to assess cardiovascular risk in type 2 diabetes has drawbacks.

Authors:  Jamie Smith; Roger Corrall
Journal:  BMJ       Date:  2003-04-19

2.  [What is diabetics' real cardiovascular risk?].

Authors:  J M Baena Díez; J L Martínez Martínez; B Alvarez Pérez; J Tomàs Pelegrina
Journal:  Aten Primaria       Date:  2002-09-30       Impact factor: 1.137

Review 3.  Effective diabetes care: a need for realistic targets.

Authors:  Peter H Winocour
Journal:  BMJ       Date:  2002-06-29

4.  Cardiovascular complications in Type 2 diabetes mellitus depend on the coronary angiographic state rather than on the diabetic state.

Authors:  C H Saely; S Aczel; T Marte; P Langer; H Drexel
Journal:  Diabetologia       Date:  2003-12-16       Impact factor: 10.122

Review 5.  Microalbuminuria and diabetic cardiovascular disease.

Authors:  Richard J MacIsaac; Mark E Cooper
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

6.  HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards.

Authors:  N Sattar; D Preiss
Journal:  Diabetologia       Date:  2012-03-08       Impact factor: 10.122

7.  [Diabetes mellitus and cardiovascular risk. Is integrated therapy of type 2 diabetes and cardiovascular risk factors necessary?].

Authors:  Domingo Orozco Beltrán; Carlos de la Sen Fernández; Vicente Gil Guillén; Concepción Carratalá Munuera; Jorge Navarro Pérez
Journal:  Aten Primaria       Date:  2010-09       Impact factor: 1.137

8.  LV Mass as a Predictor of CVD Events in Older Adults With and Without Metabolic Syndrome and Diabetes.

Authors:  Khiet Hoang; Yanglu Zhao; Julius M Gardin; Mercedes Carnethon; Ken Mukamal; David Yanez; Nathan D Wong
Journal:  JACC Cardiovasc Imaging       Date:  2015-08-26

9.  Coronary risk equivalence of diabetes assessed by SPECT-MPI.

Authors:  Donna Chelle V Morales; Sanjeev P Bhavnani; Alan W Ahlberg; Raja C Pullatt; Deborah M Katten; Donna M Polk; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2017-12-06       Impact factor: 5.952

10.  Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain.

Authors:  J M Arteagoitia; M I Larrañaga; J L Rodriguez; I Fernandez; J A Piniés
Journal:  Diabetologia       Date:  2003-06-27       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.